Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-26 @ 1:30 AM
NCT ID:
NCT02846233
Group ID:
EG000
Title:
Treatment Group
Description:
Interventions: All prandial insulin injections, usually 3 times daily before meals, will be discontinued. Basal insulin, usually once daily at bed time, will be continued at 80 % of the home dose. Albiglutide OR Dulaglutide AND Empagliflozin will be added to metformin and a basal insulin.
GLP1 receptor agonist: "Albiglutide or Dulaglutide" will be added to a basal insulin.
basal insulin: The participant will continue with the basal insulin.
SGLT2 inhibitor: "Empagliflozin" will be added to a basal insulin.
Metformin: The participant will continue with metformin.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
12
Other Number Affected:
10
Other Number At Risk:
12
Study:
NCT02846233
Results Section:
NCT02846233
Adverse Events Module:
NCT02846233